Colorectal cancer genomics: evidence for multiple genotypes which influence survival

Patrick Hugh Rooney, A. Boonsong, J. A. McKay, S. Marsh, David A J Stevenson, Graeme Ian Murray, Stephanie Curran, Neva Elizabeth Haites, J. Cassidy

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is a leading cause of cancer death and the mechanism for variable outcome in this disease is not yet fully understood. It is hypothesized that differences in the genetic make-up of tumours may be partially responsible for the differences observed in survival among same staged individuals for this disease. In this study the tumour genomes of 29 consecutive patients undergoing surgery for Dukes'C CRC were assessed by comparative genomic hybridization (CGH). In addition, the CGH profiles from the tumours were compared with those from eight colorectal cell lines. Great variation in genetic grade (all detectable aberrations i.e., loss + gain) was observed in 29 Dukes' C colorectal tumours by CGH (median four aberrations per tumour, range 0-20). Gain was found in 76% and loss in 41% of tumours. The most frequently observed regions of gain were 13q (27.6%), 20q (27.6%), 7p (24.1%), 8q (24.1%), and Iq (20.7%) and loss were 18q (31%), 4q (20.7%), 17p (20.7%), 18p (20.7%), and 15q (20.1%). None of these specific genomic aberrations were associated with patient survival. However, patients with more than two aberrations had a better survival than patients with fewer regions of loss and gain (P = 0.02). CRC cell lines had similar regions of loss or gain as the tumours. However. the frequency of genomic aberrations was much greater in the CRC cell lines. Although genomic change in CRC is relevant to the survival of patients with Dukes'C CRC, careful analysis is required to identify cell lines which are representative models of CRC genomics. (C) 2001 Cancer Research Campaign.

Original languageEnglish
Pages (from-to)1492-1498
Number of pages6
JournalBritish Journal of Cancer
Volume85
Issue number10
DOIs
Publication statusPublished - 2001

Keywords

  • CGH
  • colo-rectal tumours
  • cell lines
  • survival
  • cancer genomics
  • HYBRIDIZATION ANALYSIS
  • SOLID TUMORS
  • INSTABILITY
  • CARCINOMAS
  • GENES

Cite this

Rooney, P. H., Boonsong, A., McKay, J. A., Marsh, S., Stevenson, D. A. J., Murray, G. I., ... Cassidy, J. (2001). Colorectal cancer genomics: evidence for multiple genotypes which influence survival. British Journal of Cancer, 85(10), 1492-1498. https://doi.org/10.1054/bjoc.2001.2095

Colorectal cancer genomics: evidence for multiple genotypes which influence survival. / Rooney, Patrick Hugh; Boonsong, A.; McKay, J. A.; Marsh, S.; Stevenson, David A J; Murray, Graeme Ian; Curran, Stephanie; Haites, Neva Elizabeth; Cassidy, J.

In: British Journal of Cancer, Vol. 85, No. 10, 2001, p. 1492-1498.

Research output: Contribution to journalArticle

Rooney, PH, Boonsong, A, McKay, JA, Marsh, S, Stevenson, DAJ, Murray, GI, Curran, S, Haites, NE & Cassidy, J 2001, 'Colorectal cancer genomics: evidence for multiple genotypes which influence survival', British Journal of Cancer, vol. 85, no. 10, pp. 1492-1498. https://doi.org/10.1054/bjoc.2001.2095
Rooney, Patrick Hugh ; Boonsong, A. ; McKay, J. A. ; Marsh, S. ; Stevenson, David A J ; Murray, Graeme Ian ; Curran, Stephanie ; Haites, Neva Elizabeth ; Cassidy, J. / Colorectal cancer genomics: evidence for multiple genotypes which influence survival. In: British Journal of Cancer. 2001 ; Vol. 85, No. 10. pp. 1492-1498.
@article{7923969ff43144d293a1ac0e49cc119e,
title = "Colorectal cancer genomics: evidence for multiple genotypes which influence survival",
abstract = "Colorectal cancer (CRC) is a leading cause of cancer death and the mechanism for variable outcome in this disease is not yet fully understood. It is hypothesized that differences in the genetic make-up of tumours may be partially responsible for the differences observed in survival among same staged individuals for this disease. In this study the tumour genomes of 29 consecutive patients undergoing surgery for Dukes'C CRC were assessed by comparative genomic hybridization (CGH). In addition, the CGH profiles from the tumours were compared with those from eight colorectal cell lines. Great variation in genetic grade (all detectable aberrations i.e., loss + gain) was observed in 29 Dukes' C colorectal tumours by CGH (median four aberrations per tumour, range 0-20). Gain was found in 76{\%} and loss in 41{\%} of tumours. The most frequently observed regions of gain were 13q (27.6{\%}), 20q (27.6{\%}), 7p (24.1{\%}), 8q (24.1{\%}), and Iq (20.7{\%}) and loss were 18q (31{\%}), 4q (20.7{\%}), 17p (20.7{\%}), 18p (20.7{\%}), and 15q (20.1{\%}). None of these specific genomic aberrations were associated with patient survival. However, patients with more than two aberrations had a better survival than patients with fewer regions of loss and gain (P = 0.02). CRC cell lines had similar regions of loss or gain as the tumours. However. the frequency of genomic aberrations was much greater in the CRC cell lines. Although genomic change in CRC is relevant to the survival of patients with Dukes'C CRC, careful analysis is required to identify cell lines which are representative models of CRC genomics. (C) 2001 Cancer Research Campaign.",
keywords = "CGH, colo-rectal tumours, cell lines, survival, cancer genomics, HYBRIDIZATION ANALYSIS, SOLID TUMORS, INSTABILITY, CARCINOMAS, GENES",
author = "Rooney, {Patrick Hugh} and A. Boonsong and McKay, {J. A.} and S. Marsh and Stevenson, {David A J} and Murray, {Graeme Ian} and Stephanie Curran and Haites, {Neva Elizabeth} and J. Cassidy",
year = "2001",
doi = "10.1054/bjoc.2001.2095",
language = "English",
volume = "85",
pages = "1492--1498",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Colorectal cancer genomics: evidence for multiple genotypes which influence survival

AU - Rooney, Patrick Hugh

AU - Boonsong, A.

AU - McKay, J. A.

AU - Marsh, S.

AU - Stevenson, David A J

AU - Murray, Graeme Ian

AU - Curran, Stephanie

AU - Haites, Neva Elizabeth

AU - Cassidy, J.

PY - 2001

Y1 - 2001

N2 - Colorectal cancer (CRC) is a leading cause of cancer death and the mechanism for variable outcome in this disease is not yet fully understood. It is hypothesized that differences in the genetic make-up of tumours may be partially responsible for the differences observed in survival among same staged individuals for this disease. In this study the tumour genomes of 29 consecutive patients undergoing surgery for Dukes'C CRC were assessed by comparative genomic hybridization (CGH). In addition, the CGH profiles from the tumours were compared with those from eight colorectal cell lines. Great variation in genetic grade (all detectable aberrations i.e., loss + gain) was observed in 29 Dukes' C colorectal tumours by CGH (median four aberrations per tumour, range 0-20). Gain was found in 76% and loss in 41% of tumours. The most frequently observed regions of gain were 13q (27.6%), 20q (27.6%), 7p (24.1%), 8q (24.1%), and Iq (20.7%) and loss were 18q (31%), 4q (20.7%), 17p (20.7%), 18p (20.7%), and 15q (20.1%). None of these specific genomic aberrations were associated with patient survival. However, patients with more than two aberrations had a better survival than patients with fewer regions of loss and gain (P = 0.02). CRC cell lines had similar regions of loss or gain as the tumours. However. the frequency of genomic aberrations was much greater in the CRC cell lines. Although genomic change in CRC is relevant to the survival of patients with Dukes'C CRC, careful analysis is required to identify cell lines which are representative models of CRC genomics. (C) 2001 Cancer Research Campaign.

AB - Colorectal cancer (CRC) is a leading cause of cancer death and the mechanism for variable outcome in this disease is not yet fully understood. It is hypothesized that differences in the genetic make-up of tumours may be partially responsible for the differences observed in survival among same staged individuals for this disease. In this study the tumour genomes of 29 consecutive patients undergoing surgery for Dukes'C CRC were assessed by comparative genomic hybridization (CGH). In addition, the CGH profiles from the tumours were compared with those from eight colorectal cell lines. Great variation in genetic grade (all detectable aberrations i.e., loss + gain) was observed in 29 Dukes' C colorectal tumours by CGH (median four aberrations per tumour, range 0-20). Gain was found in 76% and loss in 41% of tumours. The most frequently observed regions of gain were 13q (27.6%), 20q (27.6%), 7p (24.1%), 8q (24.1%), and Iq (20.7%) and loss were 18q (31%), 4q (20.7%), 17p (20.7%), 18p (20.7%), and 15q (20.1%). None of these specific genomic aberrations were associated with patient survival. However, patients with more than two aberrations had a better survival than patients with fewer regions of loss and gain (P = 0.02). CRC cell lines had similar regions of loss or gain as the tumours. However. the frequency of genomic aberrations was much greater in the CRC cell lines. Although genomic change in CRC is relevant to the survival of patients with Dukes'C CRC, careful analysis is required to identify cell lines which are representative models of CRC genomics. (C) 2001 Cancer Research Campaign.

KW - CGH

KW - colo-rectal tumours

KW - cell lines

KW - survival

KW - cancer genomics

KW - HYBRIDIZATION ANALYSIS

KW - SOLID TUMORS

KW - INSTABILITY

KW - CARCINOMAS

KW - GENES

U2 - 10.1054/bjoc.2001.2095

DO - 10.1054/bjoc.2001.2095

M3 - Article

VL - 85

SP - 1492

EP - 1498

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 10

ER -